{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 2
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Seattle",
      "advisory_committee_description": "Pathology",
      "address_1": "1551 Eastlake Ave. E., Suite 200",
      "address_2": "",
      "statement_or_summary": "Summary",
      "product_code": "QDC",
      "openfda": {
        "device_name": "Dna-Based Test For Minimal Residual Disease For Hematologic Malignancies",
        "medical_specialty_description": "Pathology",
        "regulation_number": "866.6100",
        "device_class": "2",
        "registration_number": [
          "3004530258",
          "3019895551",
          "3016838963",
          "3009879426"
        ],
        "fei_number": [
          "3004530258",
          "3019895551",
          "3016838963",
          "3009879426"
        ]
      },
      "zip_code": "98102",
      "applicant": "Adaptive Biotechnologies Corporation",
      "decision_date": "2020-08-05",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "Adaptive Biotechnologies clonoSEQ Assay",
      "advisory_committee": "PA",
      "contact": "Megan  Duncan",
      "expedited_review_flag": "",
      "k_number": "K200009",
      "state": "WA",
      "date_received": "2020-01-02",
      "review_advisory_committee": "MG",
      "postal_code": "98102",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}